US 11312939
Constructs for chimeric antigen receptors
granted A61KA61K2239/13A61K2239/21
Quick answer
US patent 11312939 (Constructs for chimeric antigen receptors) held by Carisma Therapeutics Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Carisma Therapeutics Inc.
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2239/13, A61K2239/21, A61K2239/22, A61K38/00